EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Triamcinolone acetonide inhibits retinal neovascularization induced by hypoxic stimuli



Triamcinolone acetonide inhibits retinal neovascularization induced by hypoxic stimuli



ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 549



Purpose: Triamcinolone acetonide is a nonsoluble steroid that has recently been used during pars plana vitrectomy to improve visualization of the hyaloid. The inhibitory effects of triamcinolone acetonide on choroidal neovascularization have been reported experimentally and clinically. In the present study, we investigated if triamcinolone acetonide inhibited retinal neovascularization in a retinopathy of prematurity (ROP) model. Methods: Postnatal 7 days (p7) C57BL mice were exposed to 75% oxygen for 5 days. On p12, 10 ul of triamcinolone acetonide (8 mg/ml) was injected into the vitreous cavity with a 30-G needle under a stereomicroscope in 1 eye of each animal returned to room air. The other eyes were injected with the same amount of balanced salt solution (BSS) as the controls. We excluded eyes with vitreous hemorrhage and/or retinal detachment. The animals were sacrificed and the eyes were enucleated on p17. We counted the number of neovascular nuclei extending into the vitreous cavity and prepared whole-mount retinas perfused with high-molecular-weight rhodamine-conjugated dextrans to visualize retinal vessels. Results: The triamcinolone acetonide-treated eyes had a significantly decreased number of neovascular nuclei (n=8) (5.3+-2.4) compared with the BSS-treated eyes (n=8) (18.1+-13.2) (p<0.05). Whole-mount retinas showed that the vessels in the triamcinolone acetonide-treated eyes were less tortuous and engorged than those in the BSS-treated eyes. Conclusions: This study showed that triamcinolone acetonide inhibits retinal neovascularization and improves the morphologic changes of retinal vessels in an ROP model.

(PDF 0-2 workdays service: $29.90)

Accession: 035985946

Download citation: RISBibTeXText



Related references

Effect of intravitreal triamcinolone acetonide on retinal apoptosis in experimental retinal neovascularization. Graefe's Archive for Clinical and Experimental Ophthalmology 246(7): 1069-1070, 2008

Suppression of experimental pre retinal neovascularization with intravitreal triamcinolone acetonide. Investigative Ophthalmology & Visual Science 32(4): 1046, 1991

The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefe's Archive for Clinical & Experimental Ophthalmology 231(1): 34-40, 1993

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Archives of Ophthalmology 119(3): 399-404, 2001

Simultaneous determination of triamcinolone acetonide palmitate and triamcinolone acetonide in beagle dog plasma by UPLC-MS/MS and its application to a long-term pharmacokinetic study of triamcinolone acetonide palmitate lipid emulsion injection. Journal of Pharmaceutical and Biomedical Analysis 104: 105-111, 2015

Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide. Retina 25(4): 503-509, 2005

The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. Journal of Pharmacology and Experimental Therapeutics 315(3): 1036-1045, 2005

Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 57(4): 1026-1033, 2008

Natural history of sub-retinal triamcinolone acetonide deposition after triamcinolone-assisted vitrectomy. International Ophthalmology 28(5): 359-362, 2007

A moephologic study of retinal toxicity induced by triamcinolone acetonide vehicles in rabbit eyes. Retina 28(3): 504-510, 2008

Preservative-free triamcinolone acetonide injectable suspension versus "traditional" triamcinolone preparations: impact of aggregate size on retinal biocompatibility. Retina 31(10): 2050-2057, 2012

Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology 249(2): 215-222, 2011

Inhibitory effect of triamcinolone acetonide on corneal neovascularization. Graefe's Archive for Clinical and Experimental Ophthalmology 244(2): 205-209, 2005

Sub-Tenon's injection of triamcinolone acetonide for choroidal neovascularization. Nippon Ganka Gakkai Zasshi 110(1): 19-24, 2006